Rare diseases
Investigational molecules
Locations
No 3 898 Lane Halei Road, Trade Zone, 201203
Abbisko Therapeutics Co. Ltd. demonstrates a concentrated focus on advancing cancer treatment through innovative therapeutic approaches. The organization's research portfolio emphasizes the development of novel anti-cancer agents designed to address unmet medical needs in oncology. Their investigational programs target critical pathways involved in tumor growth and cancer cell proliferation, reflecting a commitment to developing next-generation therapies for patients with malignant diseases.
The sponsor's international research network spans multiple countries across different continents, enabling comprehensive evaluation of cancer therapeutics in diverse patient populations. This global approach supports the development of treatments with potential applicability across various demographic groups and healthcare settings, particularly focusing on advanced malignancies and conditions where current therapeutic options remain limited.
Abbisko Therapeutics Co. Ltd. runs clinical trials in conditions such as Giant cell tumour of tendon sheath, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
